FDA Drops Two-Trial Requirement For Drugs
WASHINGTON — The Food and Drug Administration said Wednesday it will make one pivotal study the default standard for approving new drugs and novel health products, FDA Commissioner Marty Makary and deputy Vinay Prasad…